Kyntra Bio, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Thane Wettig, with a market cap of $27.7M.
Based on Q1 2026 filing
Common questions about Kyntra Bio, Inc. Common Stock
Kyntra Bio, Inc. Common Stock (KYNB) has a market capitalization of $27.7M and trades on NASDAQ.